Biota Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 19   

Articles published

BOTA 3.04 +0.01 (0.33%)
price chart
Biotech Insider Buying: Biota Pharmaceuticals Inc. (NASDAQ:BOTA), Omeros ...
Biota Pharmaceuticals Inc. (NASDAQ:BOTA) CEO Russell H. Plumb purchased 32,031 shares of the stock on the open market in a transaction that occurred on Wednesday, June 11th.
Biotech Volatile Stocks; Biota Pharmaceuticals Inc (NASDAQ:BOTA), Alder ...  Gaining Green
Related articles »  
Biotech Insider Buying: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Biota ...
Following the acquisition, the chief executive officer now directly owns 127,579 shares of the company's stock, valued at approximately $381,461.
Biotech Insider Buying: Amicus Therapeutics, Inc. (NASDAQ:FOLD), OHR ...  Markets Insider
Related articles »  
Healthcare Insider Selling: Oncomed Pharmaceuticals (NASDAQ:OMED), Biota ...
Oncomed Pharmaceuticals Inc. (NASDAQ:OMED) Director Denise Pollard-Knight sold 64,561 shares of the stock in a transaction dated Tuesday, June 24th.
Related articles »  
Healthcare Losers: Ultragenyx Pharmaceutical Inc (NASDAQ:RARE), Actinium ...
The supported treatments included influenza A and B. Biota Pharmaceuticals Inc (NASDAQ:BOTA) shares moved down -6.00% in last trading session and was closed at $3.29, while trading in range of $3.26-$3.50.
Related articles »  
Stocks to Watch : Linn Energy LLC (NASDAQ:LINE), US Ecology Inc (NASDAQ ...
Biota Pharmaceuticals Inc (NASDAQ:BOTA), CEO Russell H. Plumb bought 32,031 shares of Biota Pharmaceuticals stock in a transaction that occurred on Wednesday, June 11th.
Healthcare Insider Buying: Opko Health (NYSE:OPK), American Apparel ...
Following the acquisition, the chief executive officer now directly owns 127,579 shares of the company's stock, valued at approximately $381,461.
Skin Infections - Pipeline Review, H1 2014
The Companies Mentioned in this report are GlaxoSmithKline plc Takeda Pharmaceutical Company Limited Melinta Therapeutics, Inc The Medicines Company Toyama Chemical Co.
Related articles »  
Biota Pharmaceuticals Inc prices $25 mln public offering